Nema Vijay
Division of Microbiology and Clinical Pathology, National AIDS Research Institute, Pune, Maharashtra, India.
Lung India. 2012 Jul;29(3):259-66. doi: 10.4103/0970-2113.99112.
Tuberculosis (TB) has been a disease affecting almost all parts of the world since ages. Lot many efforts came in the past for improving diagnosis and treatment. Also, an effective vaccine has been sought after for long. With the emergence of resistant strains of Mycobacterium tuberculosis, the causal organisms of tuberculosis, and complexities emerging due to other associated infections and disease conditions, there is a desperate need for further research input in the field. Be it the better medication and care or better resistance management, proper diagnostics holds the key to success. It has been observed that a high burden of the disease was accompanied by resource limitations and poor research set-up. The scenario remained like this for several decades. With the refreshed vision of resourceful countries and funding agencies, funding is being provided in many areas of research in tuberculosis diagnosis and treatment. This review has been written with an aim to bring forth the limitations of available methods in the field of diagnostics and making researchers aware about the changing scenario with better funding opportunities and support. The author visualizes an enthusiasm from all over the world for the development of better modalities and urges scientists to join the struggle at this very perfect time to take the challenge and come forward with innovations in this field.
自古以来,结核病一直是一种影响着世界几乎所有地区的疾病。过去为改善诊断和治疗付出了诸多努力。此外,长期以来一直在寻求一种有效的疫苗。随着结核分枝杆菌耐药菌株的出现,结核病的致病原,以及由于其他相关感染和疾病状况而出现的复杂性,该领域迫切需要进一步的研究投入。无论是更好的药物治疗和护理,还是更好的耐药管理,正确的诊断都是成功的关键。据观察,该疾病的高负担伴随着资源限制和研究设施简陋。这种情况持续了几十年。随着资源丰富的国家和资助机构的观念更新,结核病诊断和治疗的许多研究领域都获得了资金支持。撰写这篇综述的目的是揭示诊断领域现有方法的局限性,并让研究人员了解随着更好的资金机会和支持而不断变化的情况。作者预见到全世界对开发更好方法的热情,并敦促科学家们在这个绝佳时机加入这场斗争,迎接挑战,在该领域拿出创新成果。